A framework for rehabilitation of neurodegenerative diseases: Planning Care and Maximizing Quality of Life

Neurology Report

Volumn 26, Issue 3, 2002, Pages 115-129

  Bello Haas, Vanina Dal ^a  

^a CLEVELAND STATE UNIVERSITY   (United States)

Author keywords

Disease stages; Framework; Nagi model; Neurodegenerative diseases; Therapeutic care continuum

Indexed keywords

EID: 84979001139     PISSN: 1085049X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01253086-200226030-00003     Document Type: Article

References (84)

1. Nagi S. Disability concepts revisited: implications for prevention. In: Pope A, Tarlov A, eds. Disability in America: Toward a National Agenda for Prevention. Washington, DC: Institute of Medicine, National Academy Press; 1991.
2. American Physical Therapy Association. Guide to Physical Therapist Practice. 2nd ed. Phys Ther. 2001; 81: 9-744.
3. Schenkman M, Bliss ST, Day L, Kemppainen S, Morse J, Pratt J. Multisystem model for management of neuro-logically impaired adults-an update and illustrative case. Neurol Rep. 1999; 23: 145-157.
4. Cutson TM, Laub KC, Schenkman M Pharmacological and nonpharmacological interventions in the treatment of Parkinson’s disease. Phys Ther. 1995; 32: 363-373.
5. Hoehn MM, Yahr MD. Parkinsonism: Onset, progression and mortality. Neurology. 1967; 17: 427-442.
6. Sinaki M. Rehabilitation. In: Mulder DW, ed. The Diagnosis and Treatment of Amyotrophic Lateral Sclerosis. Boston, Mass: Houghton Mifflin; 1980.
7. Morris ME. Movement disorders in people with Parkinson disease: A model for physical therapy. Phys Ther. 2000; 80: 578-597.
8. K Glendinning D. A rationale for strength training in patients with Parkinson’s disease. Neurol Rep. 1997; 21: 132-135.
9. Dal Bello-Haas VP, Kloos AD, Florence JM, et al. A Preliminary Study: The effects of a strengthening program on maximum voluntary isometric contraction, functional abilities, fatigue and quality of life in patients with amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis Other Motor Neuron Disord. 2001; 2(S2): 93-103
10. Bridgewater KJ, Sharpe MH. Trunk muscle performance in early Parkinson’s disease. Phys Ther. 1998; 78: 567-576.
11. Schenkman M, Cutson TM, Kuchibhatla M, et al. Exercise to improve spinal flexibility and function for people with Parkinsons disease: a randomized controlled trial. J Am Ger Soc. 1998; 46: 1207-1216.
12. MacLaren J. Rehabilitation through advocacy and empowerment. Br J Ther Rehabil. 1996; 3: 492-497.
13. Jette AM. The relationship of quality of life to the disablement concept. Phys Ther. 1994; 74: 380-386.
14. Abresch RT, Seyden NK, Wineinger MA. Quality of life. Phys Med Rehabil Clin North Am. 1998; 9: 233-247.
15. Hogg K, Goldstein LH, Leigh PN. The psychological impact of motor neuron disease. Psychol Med. 1994; 24: 626-632.
16. Hunter MD, Robinson IC, Neilson S. The functional and psychological status of patients with amyotrophic lateral sclerosis: Some implications for rehabilitation. Disability Rehabil. 1993; 15: 119-126.
17. Goldstein LH, Adamson M, Jeffrey L, et al. The psychological impact of MND on patients and carers. J Neurol Sci. 1998; 160(S 1): S 114-S121.
18. IS Schrag A, Jahanshahi M, Quinn N. What contributes to quality of life in patients with Parkinson’s disease. Neurol Neurosurg Psychiatry. 2000; 69: 308-312.
19. Kupio AM, Marttila RJ, Helenius H, Toivonen M, Rinne UK. The quality of life in Parkinson’s disease. Mov Disord. 2000; 15: 216-223.
20. Kopias PA, Gans HB, Wisely MP, et al. Quality of life in Parkinson’s disease. J Gerontol A Biol Sci Med Sci. 1999; 54A: M197-M202.
21. Wallhagen MI, Brod M. Perceived control and wellbeing in Parkinson’s disease. West J Nurs Res. 1997; 19: 11-31.
22. Petajan JH, Gappmaier E, White AT. Impact of aerobic training on fitness and quality of life in multiple sclerosis. Ann Neurol. 1996; 39; 432-44l.
23. Dura JR, Haywood-Niler E, Kiecolt-Glaser JK. Spousal caregivers of persons with Alzheimer’s and Parkinson’s disease dementia: A preliminary comparison. The Gerontologist. 1990; 30: 332-336.
24. Schenkman M, Zhu CW, Cutson TM, Whetten-Goldstein K. Longitudinal evaluation of economic and physical impact of Parkinson’s disease. Parkinsonism Related Disord. 2001; 8: 41-50.
25. Rumrill PD, Kaleta DA, Batterby JC. In: Rumrill PD. Employment Issues and Multiple Sclerosis. New York, NY: Demos; 1996: 1-18.
26. Whetten-Goldstein K, Sloan FA, Goldstein LB, Kulas ED. A comprehensive assessment of the cost of multiple sclerosis in the United States. Multiple Sclerosis. 1998; 4: 419-425.
27. Folstein S. Huntington's Disease: A Disorder of Families. Baltimore, Md: John Hopkins University Press; 1989. Gutekunst CA, Norflus F, Hersch SM. Recent advances in Huntington’s disease. Curr Opinions Neurol. 2000; 13: 445-450.
28. Brawer I, Blumenfeld N, Bender A. Neuromuscular diseases and individual differences. In: Charash LI, Lovelace RE, Wolf SG, Kutscher AH, Roye DP, Leach CF, eds. Realities in Coping with Progressive Neuromuscular Diseases. Philadelphia, Pa: The Charles Press Publishers, Inc.; 1987: 197-202.
29. Marsden CO. Parkinson’s disease. J Neurol Neurosurg Psychiatry. 1994; 57: 672-681.
30. Wasner M, Klier H, Borasio GD. The use of alternative medicine by patients with amyotrophic lateral sclerosis. J Neurol Sci. 2001; 191: 151-154.
31. Berkman CS. Pignotti MG, Cavallo PF, Holland NJ. Use of alternative treatments by people with multiple sclerosis. Neurorehabil Neural Repair. 1999; 13: 243-254.
32. Schwartz CE, Laitin E, Brotman S, LaRocca N. Utilization of unconventional treatments by persons with MS: is it alternative or complementary? Neurology. 1999; 52: 626-629.
33. Imbriglio S. Huntington’s disease at mid-stage. Clin Manage. 1992; 12: 62-72.
34. Dal Bello-Haas V. Andrews-Hinders D, Balsdon Richer C, et al. Development, analysis, refinement and utility of an interdisciplinary amyotrophic lateral sclerosis database. Amyotrophic Lateral Sclerosis Other Motor Neuron Disord. 2001; 2: 39-46.
35. Rando T. Grief Dying, and Death: Clinical Interventions for Caregivers. Champaign, 111: Research Press Company; 1984.
36. Bradley W. Amyotrophic lateral sclerosis and Duchenne muscular dystrophy: the diseases and the doctor-patient relationship. In: Charash LI, Lovelace RE, Wolf SG, Kutscher AH, Roye DP, Leach CF, eds. Realities in Coping with Progressive Neuromuscular Diseases. Philadelphia, Pa: The Charles Press Publishers, Inc.; 1987: 197-202.
37. DiFabio RP, Choi, T, Soderber J, Hansen CR. Health-related quality of life for patients with progressive multiple sclerosis: Influence of rehabilitation. Phys Ther. 1997; 77: 1704-1716.
38. Miller RG, Anderson FA, The ALS C. A. R. E. Study Group. The ALS patient care database. In: Mitsumoto H., M unsat TL, eds. Amyotrophic Lateral Sclerosis: A Guide for Patients and Families. 2nd ed. New York, NY: Demos; 2001: 233-240.
39. Dal Bello-Haas V, KIoos A, Mitsumoto H. Physical therapy for a patient through six stages of Amyotrophic Lateral Sclerosis. Phys Ther. 1998; 78: 1312-1324.
40. Hallum A. Neuromuscular diseases. In: Umphred DA, ed. Neurological Rehabilitation. 4th ed. St. Louis, Mo: Mosby; 2001: 363-385.
41. Kilmar DD, McCrory MA, Wright NC, Aitkens SG, Bernauer EM. The effect of a high resistance exercise program in slowly progressive neuromuscular disease. Arch Phys Med Rehabil. 1994; 75: 560-563
42. Lindeman E, Leffers P, Spaans F, Drukker J, et al. Strength training in patients with myotonic dystrophy and hereditary motor and sensory neuropathy: A randomized clinical trial. Arch Phys Med Rehabil. 1995; 76: 612-620.
43. Aitkens SG, McCrory' MA, Kilmer DD, Bernauer EM. Moderate resistance exercise program: its effect in slowly progressive neuromuscular disease. Arch Phys Med Rehabil. 1993; 74: 711-715.
44. Milner-Brown HS, Miller RG. Muscle strengthening through electric stimulation combined with low-resis-tance weights in patients with neuromuscular disorders. Arch Phys Med Rehabil. 1988; 69: 20-22.
45. Florence JM, Hagberg JM. Effects of training on the exercise response of neuromuscular disease patients. Med Sci Sports Exerc. 1984; 16: 460-465.
46. Vignos PJ Jr. Physical models of rehabilitation in neuromuscular disease. Muscle Nerve. 1983; 6: 323-338.
47. Bohannon RW. Results of resistance exercise on a patient with amyotrophic lateral sclerosis. Phys Ther. 1983; 63: 965-968.
48. Sanjak M, Paulson D, Sufit R, et al. Physiologic and metabolic response to progressive and prolonged exercise in amyotrophic lateral sclerosis. Neurol. 1987: 37: 1217-1220.
49. Pinto AC, Alves M, Nogueira A. Can amyotrophic lateral sclerosis patients with respiratory' insufficiency exercise? J Neurol Sci. 1999; 169: 69-75.
50. Drory VE, Goltsman E, Reznik JG, Mosek A, Korczyn AD. The value of muscle exercise in patients with amyotrophic lateral sclerosis. J Neurol Sci. 2001; 191: 133-137.
51. Tian J, Herdman SJ, Zee DS, Folstein SE. Postural instability in patients with Huntington’s disease. Neurol. 1992; 42: 1232-1238.
52. Thompson PD, Berardelli A, Rothwell JC, et al. The coex istence of bradykinesia and chorea in Huntington’s disease and its implications for theories of basal ganglia control of movement. Brain. 1988; 111: 223-244.
53. Hefter H, Homberg V, Lange HW, Freund HI. Impairment of rapid movements in Huntington’s disease. Brain. 1987; 110: 585-612.
54. Agostino R, Berardelli A, Formica A, Accornero N, Manfredi M. Sequential arm movements in patients with Parkinson’s disease, Huntington’s disease and dystonia. Brain. 1992; 115: 1481-1495.
55. Georgiou N, Bradshaw JL, Philips JG, Chiou E, Bradshaw JA. Reliance on advance information and movement sequencing in Huntington’s disease. Mov Disord. 1985; 10: 477-481.
56. Hausdorff JM, Cudkowicz ME, Firtion R, Wei JY, Goldberger AL. Gait variability and basal ganglia disorders: stride-to-stride variations of gait cycle timing in Parkinson’s disease and Huntington’s disease. Mov Disord 1998; 13: 428-437.
57. Reynolds NC, Myklebust JB, Prietro TE, Myklebust BM. Analysis of gait abnormalities in Huntington disease. Arch Pbys Med Rehabil. 1999; 80: 59-65.
58. Churchyard ME, Morris ME, Georgiou N, Chiu E, Cooper R, Iansek R. Gait dysfunction in Huntington’s disease: Parkinsonism and a disorder of timing. Adv Neurol. 2001; 87: 375-385.
59. Quinn L, Reilmann R, Marder K, Gordon AM. Altered movement trajectories and force control during object transport in Huntington’s disease. Mov Disord. 2001; 16: 469-480.
60. Imbriglio S. Physical and Occupational Therapy for Huntington's Disease. New York, NY: Huntington’s Disease Society of America; 1997.
61. O’Sullivan SB. Multiple sclerosis. In: O’Sullivan SB, Schmitz TJ, eds. Physical Rehabilitation: Assessment and Treatment. 4th ed. Philadelphia, Pa: F. A. Davis Company; 2001: 715-745.
62. Kasser SL, Rose DJ, Clark S. Balance training for adults with multiple sclerosis: multiple case studies. Neurol Rep. 1999; 23: 5-12.
63. Stephens J, DuShuttle D, Hatcher C, Shmunes J, Slaninka C. Use of Awareness Through Movement improves balance and balance confidence in people with multiple sclerosis: A randomized controlled study. Neurol Rep. 2001; 25: 39-49.
64. Kraft GH, Alquist AD, deLateur BJ. Effects of resistance exercise on strength in patients with multiple sclerosis. Rehabil R&D Prog Rep. 1996; 33: 329-330.
65. Svensson B, Gerdle B, Elert J. Endurance training in patients with multiple sclerosis: Five case studies. Pbys Ther. 1994; 74: 1017-1026.
66. Kirsch N, Myslinski MJ. The effect of a personally designed fitness program on the aerobic capacity and function for two individuals with multiple sclerosis. Pbys Ther Case Rep. 1999; 2: 19-26.
67. DiFabio RP, Sodcrberg J, Choi T, Hansen CR, Schapiro RT. Extended outpatient rehabilitation: its influence on symptom frequency, fatigue, and functional status for persons with progressive multiple sclerosis. Arch Pbys Med Rehabil. 1998; 79: 141-146.
68. Freeman JA, Langdon DW, Hobart JC, Thompson AJ. Inpatient rehabilitation in multiple sclerosis: Do the benefits carry over into the community? Neurology. 1999; 52: 50-56.
69. Freeman JA, Langdon DW, Hobart JC. The impact of inpatient rehabilitation on progressive multiple sclerosis. Ann Neurol. 1997; 42: 236-244.
70. Solari A, Filippini G, Gasco P, et al. Physical rehabilitation has a positive effect on disability in multiple sclerosis patients. Neurol. 1999; 52: 57-64.
71. Wiles CM, Newcombe RG, Fuller KJ, et al. Controlled randomized crossover trial of the effects of physiotherapy on mobility in chronic multiple sclerosis. J Neurol Neurosurg Psychiatry. 2001; 70: 174-179.
72. Dibble LE, Nicholson DE. Sensory cuing improves motor performance and rehabilitation in persons with Parkinson’s disease. Neurol Rep. 1997; 21: 117-124.
73. Dam M, Tonin P, Casson S, et al. Effects of sensory-enhanced physiotherapy on disability of Parkinson’s disease patients. Adv Neurol. 1996; 69: 551-555.
74. Dietz MA, Goetz CG, Stebbins GT. Evaluation of a modified inverted walking stick as a treatment for Parkinsonians’freezing episodes. Mov Disord. 1990; 5: 234-247.
75. Morris ME, Iansek R, Matyas TA, Summers JJ. Ability to modulate walking cadence remains intact in Parkinson’s disease. J Neurol Neurosurg Psychiatry. 1994; 57: 1532-1534.
76. Morris ME, Iansek R, Matyas TA, Summers JJ. The pathogenesis of gait hypokinesia in Parkinson’s disease. Brain. 1994; 117: 1169-1181.
77. Morris ME, Iansek R, Matyas TA, Summers JJ. Stride length regulation in Parkinson’s disease: Mormalization strategies and underlying mechanisms. Brain. 1996; 119: 551-568.
78. Thaut MH, McIntosh GC, Rice RR, Miller RA, Rathburn J, Brault JM. Rhythmic auditory stimulation in gait training for Parkinson’s disease patients. Mov Disord. 1996; 11: 193-200.
79. McIntosh GC, Brown SH, Rice RR, Thaut MH. Rhythmic auditory-motor facilitation of gait patterns in patients with Parkinson’s disease. J. Neurol Neurosurg Psychiatry. 1997; 62: 22-26.
80. Cornelia CL, Stebbins GT, Brown-Toms N, Goetz CG. Physical therapy and Parkinson’s disease: A controlled clinical trial. Neurology. 1994; 44: 376-378.
81. Curtis CL, Bassile CC, Cote LJ, Gentile AM. Effects of exercise on the motor control of individuals with Parkinson’s disease: case studies. Neurol Rep. 2001; 25: 2-11.
82. Scandalis TA, Bosak A, Berliner JC, Helman LL, Wells MR. Resistance training and gait function in patients with Parkinson’s disease. Am J Pbys Med Rehabil. 2001; 80; 38-43.
83. Bridgewater KJ, Sharpe MH. Aerobic exercise and early Parkinson’s disease. J Neurol Rehabil. 1996; 10: 233-241.
84. Baatile J, Langbein WE, Weaver F, Maloney C, Jost MB. Effect of exercise on perceived quality of life of individuals with Parkinson’s disease. J Rehabil Res Develop. 2000; 37: 529-534.